Literature DB >> 28614711

DAPK1 Mediates LTD by Making CaMKII/GluN2B Binding LTP Specific.

Dayton J Goodell1, Vincent Zaegel2, Steven J Coultrap2, Johannes W Hell3, K Ulrich Bayer4.   

Abstract

The death-associated protein kinase 1 (DAPK1) is a potent mediator of neuronal cell death. Here, we find that DAPK1 also functions in synaptic plasticity by regulating the Ca2+/calmodulin (CaM)-dependent protein kinase II (CaMKII). CaMKII and T286 autophosphorylation are required for both long-term potentiation (LTP) and depression (LTD), two opposing forms of synaptic plasticity underlying learning, memory, and cognition. T286-autophosphorylation induces CaMKII binding to the NMDA receptor (NMDAR) subunit GluN2B, which mediates CaMKII synaptic accumulation during LTP. We find that the LTP specificity of CaMKII synaptic accumulation is due to its LTD-specific suppression by calcineurin (CaN)-dependent DAPK1 activation, which in turn blocks CaMKII binding to GluN2B. This suppression is enabled by competitive DAPK1 versus CaMKII binding to GluN2B. Negative regulation of DAPK1/GluN2B binding by Ca2+/CaM results in synaptic DAPK1 removal during LTP but retention during LTD. A pharmacogenetic approach showed that suppression of CaMKII/GluN2B binding is a DAPK1 function required for LTD.
Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CaMKII; DAPK1; GluN2B; LTD; LTP; calcineurin; death-associated protein kinase; dendritic spine; hippocampus; synapse

Mesh:

Substances:

Year:  2017        PMID: 28614711      PMCID: PMC5549467          DOI: 10.1016/j.celrep.2017.05.068

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  62 in total

Review 1.  LTP and LTD: an embarrassment of riches.

Authors:  Robert C Malenka; Mark F Bear
Journal:  Neuron       Date:  2004-09-30       Impact factor: 17.173

2.  Transition from reversible to persistent binding of CaMKII to postsynaptic sites and NR2B.

Authors:  K Ulrich Bayer; Eric LeBel; Greg L McDonald; Heather O'Leary; Howard Schulman; Paul De Koninck
Journal:  J Neurosci       Date:  2006-01-25       Impact factor: 6.167

3.  Neuronal Activity and CaMKII Regulate Kinesin-Mediated Transport of Synaptic AMPARs.

Authors:  Frédéric J Hoerndli; Rui Wang; Jerry E Mellem; Angy Kallarackal; Penelope J Brockie; Colin Thacker; David M Madsen; Andres V Maricq
Journal:  Neuron       Date:  2015-04-02       Impact factor: 17.173

4.  Autonomous CaMKII mediates both LTP and LTD using a mechanism for differential substrate site selection.

Authors:  Steven J Coultrap; Ronald K Freund; Heather O'Leary; Jennifer L Sanderson; Katherine W Roche; Mark L Dell'Acqua; K Ulrich Bayer
Journal:  Cell Rep       Date:  2014-01-30       Impact factor: 9.423

5.  The pro-apoptotic function of death-associated protein kinase is controlled by a unique inhibitory autophosphorylation-based mechanism.

Authors:  G Shohat; T Spivak-Kroizman; O Cohen; S Bialik; G Shani; H Berrisi; M Eisenstein; A Kimchi
Journal:  J Biol Chem       Date:  2001-09-28       Impact factor: 5.157

6.  Multiple mechanisms for the potentiation of AMPA receptor-mediated transmission by alpha-Ca2+/calmodulin-dependent protein kinase II.

Authors:  Jean Christophe Poncer; Jose A Esteban; Roberto Malinow
Journal:  J Neurosci       Date:  2002-06-01       Impact factor: 6.167

7.  NMDA induces long-term synaptic depression and dephosphorylation of the GluR1 subunit of AMPA receptors in hippocampus.

Authors:  H K Lee; K Kameyama; R L Huganir; M F Bear
Journal:  Neuron       Date:  1998-11       Impact factor: 17.173

8.  Dual mechanism of a natural CaMKII inhibitor.

Authors:  Rebekah S Vest; Kurtis D Davies; Heather O'Leary; J David Port; K Ulrich Bayer
Journal:  Mol Biol Cell       Date:  2007-10-17       Impact factor: 4.138

9.  CaMKII binding to GluN2B is differentially affected by macromolecular crowding reagents.

Authors:  Dayton J Goodell; Tatiana A Eliseeva; Steven J Coultrap; K Ulrich Bayer
Journal:  PLoS One       Date:  2014-05-05       Impact factor: 3.240

10.  Activation of CaMKII in single dendritic spines during long-term potentiation.

Authors:  Seok-Jin R Lee; Yasmin Escobedo-Lozoya; Erzsebet M Szatmari; Ryohei Yasuda
Journal:  Nature       Date:  2009-03-19       Impact factor: 49.962

View more
  29 in total

Review 1.  CaM Kinase: Still Inspiring at 40.

Authors:  K Ulrich Bayer; Howard Schulman
Journal:  Neuron       Date:  2019-08-07       Impact factor: 17.173

2.  Long-Term Depression Is Independent of GluN2 Subunit Composition.

Authors:  Jonathan M Wong; John A Gray
Journal:  J Neurosci       Date:  2018-03-28       Impact factor: 6.167

3.  Molecular Mechanisms of Non-ionotropic NMDA Receptor Signaling in Dendritic Spine Shrinkage.

Authors:  Ivar S Stein; Deborah K Park; Juan C Flores; Jennifer N Jahncke; Karen Zito
Journal:  J Neurosci       Date:  2020-04-22       Impact factor: 6.167

4.  Positive Modulation of SK Channel Impedes Neuron-Specific Cytoskeletal Organization and Maturation.

Authors:  Amita Shrestha; Razia Sultana; Philip A Adeniyi; Charles C Lee; Olalekan M Ogundele
Journal:  Dev Neurosci       Date:  2020-06-24       Impact factor: 2.984

5.  Simultaneous Live Imaging of Multiple Endogenous Proteins Reveals a Mechanism for Alzheimer's-Related Plasticity Impairment.

Authors:  Sarah G Cook; Dayton J Goodell; Susana Restrepo; Don B Arnold; K Ulrich Bayer
Journal:  Cell Rep       Date:  2019-04-16       Impact factor: 9.423

Review 6.  CaMKII regulates the depalmitoylation and synaptic removal of the scaffold protein AKAP79/150 to mediate structural long-term depression.

Authors:  Kevin M Woolfrey; Heather O'Leary; Dayton J Goodell; Holly R Robertson; Eric A Horne; Steven J Coultrap; Mark L Dell'Acqua; K Ulrich Bayer
Journal:  J Biol Chem       Date:  2017-12-01       Impact factor: 5.157

7.  Young DAPK1 knockout mice have altered presynaptic function.

Authors:  Dayton J Goodell; Jonathan E Tullis; K Ulrich Bayer
Journal:  J Neurophysiol       Date:  2021-04-21       Impact factor: 2.714

8.  Integrative genomic analysis of PPP3R1 in Alzheimer's disease: a potential biomarker for predictive, preventive, and personalized medical approach.

Authors:  Chuansheng Zhao; Mei Zhao; Zhike Zhou; Jun Bai; Shanshan Zhong; Rongwei Zhang; Kexin Kang; Xiaoqian Zhang; Ying Xu
Journal:  EPMA J       Date:  2021-11-15       Impact factor: 6.543

Review 9.  Regulation of NMDA glutamate receptor functions by the GluN2 subunits.

Authors:  Marta Vieira; Xuan Ling Hilary Yong; Katherine W Roche; Victor Anggono
Journal:  J Neurochem       Date:  2020-02-16       Impact factor: 5.546

Review 10.  Regulation of the NMDA receptor by its cytoplasmic domains: (How) is the tail wagging the dog?

Authors:  Yevheniia Ishchenko; Melissa G Carrizales; Anthony J Koleske
Journal:  Neuropharmacology       Date:  2021-06-20       Impact factor: 5.273

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.